Impeding U.S. generic drug use criticized

Apr 19, 2006

Moves by branded drug companies to slow the spread of U.S. generic drugs has been criticized by a pharmacy benefit managers' organization.

"There's an agenda to prevent generics from getting to the market as soon as they could," said Mark Merritt, president of the Pharmaceutical Care Management Association.

There are an unprecedented number of top-selling drugs scheduled to go off patent within five years, and the organization said branded drug companies are creating hurdles to potential savings of $23 billion to seniors and the Medicare system.

The association identified 14 drugs commonly used by older people that are set to go off patent by 2010, including the cholesterol drugs Zocor and Pravachol, the antidepressant Zoloft and the prostate medication Proscar.

Under federal legislation passed in 1984, drug makers have 20 years after discovery of a drug to sell it exclusively, but some drug companies are lobbying for longer patent exclusivity.

"Many of the branded companies have pretty empty pipelines, with few big blockbusters on the horizon," Merritt said. "So they're fighting to keep their current big sellers free of competition."

Copyright 2006 by United Press International

Explore further: New Mexico students join others in nation against new tests

add to favorites email to friend print save as pdf

Related Stories

Challenges for doctors using fitness trackers and apps

Feb 20, 2015

More hospitals and doctors are starting to use data from fitness trackers and health apps to help treat patients. But they are moving cautiously. The technology has a lot of potential, but there are key ch ...

The promiscuity of chemical probes discovered

Feb 19, 2015

Researchers at IMIM (Hospital del Mar Medical Research Institute) have applied a new computational methodology to anticipate the degree of selectivity of the molecules that are used to study protein functions ...

Synthetic biology yields new approach to gene therapy

Feb 16, 2015

Bioengineers at The University of Texas at Dallas have created a novel gene-delivery system that shuttles a gene into a cell, but only for a temporary stay, providing a potential new gene-therapy strategy ...

Recommended for you

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.